1. Feasibility and safety of conservative surgery for the treatment of spermatic cord leiomyosarcoma. (December 2015) Authors: Bozzini, G.; Albersen, M.; Romero Otero, J.; Margreiter, M.; Garcia Cruz, E.; Mueller, A.; Gratzke, C.; Serefoglu, E.C.; Martinez Salamanca, J.I.; Verze, P. Journal: International journal of surgery Issue: Volume 24:Part A(2015) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centers. Issue 11 (November 2016) Authors: Gandaglia, G.; Karl, A.; Novara, G.; de Groote, R.; Buchner, A.; D'Hondt, F.; Montorsi, F.; Stief, C.; Mottrie, A.; Gratzke, C. Journal: European journal of surgical oncology Issue: Volume 42:Issue 11(2016:Nov.) Page Start: 1736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PH-0659 Metastasis-free survival after salvage radiotherapy in post-operative prostate cancer patients in the PSMA PET/CT era – a bi-institutional, retrospective analysis. (August 2021) Authors: Schmidt-Hegemann, N.; Grosu, A.L.; Ruf, J.; Gratzke, C.; Adebahr, S.; Stief, C.; Bartenstein, P.; Belka, C.; Li, M.; Trapp, C.; Rogowski, P.; Zamboglou, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1329 Longterm Biochemical Recurrence-Free Survival after PSMA-PET/CT–Based Salvage Radiotherapy. (August 2021) Authors: Adebahr, S.; Zamboglou, C.; Ruf, J.; Gratzke, C.; Kirste, S.; Spohn, S.; Stief, C.; Bartenstein, P.; Belka, C.; Li, M.; Trapp, C.; Rogowski, P.; Grosu, A.; Grosu, A.; Schmidt-Hegemann, N. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1414 Results of a concept-development for a phase III trial on radiotherapy in primary prostate cancer. (May 2022) Authors: Spohn, S.; Adebahr, S.; Huber, M.; Jenkner, C.; Wiehle, R.; Nagavci, B.; Schmucker, C.; Carl, E.; Chen, R.; Weber, W.; Mix, M.; Rühle, A.; Nicolay, N.; Gratzke, C.; Benndorf, M.; Wiegel, T.; Weis, J.; Baltas, D.; Zamboglou, C.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41‐2272 and BAY 60‐2770 alone or in combination with a phosphodiesterase type 5 inhibitor. Issue 8 (17th September 2014) Authors: Füllhase, C.; Hennenberg, M.; Sandner, P.; Strittmatter, F.; Niedworok, C.; Bauer, R.M.; Gratzke, C.; Soler, R.; Stief, C.; Andersson, K.E. Journal: Neurourology and urodynamics Issue: Volume 34:Issue 8(2015:Nov.) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗